Related Experiment Videos
Residual carcinoma in bronchial resection line
Annales Chirurgiae Et Gynaecologiae
|January 1, 1986
Summary
Detecting microscopic residual carcinoma in bronchial resection lines can prevent bronchopleural fistulas. Intraoperative frozen sections are recommended to identify residual tumors and improve patient outcomes after pulmonary carcinoma surgery.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Pulmonary Medicine
Background:
- Microscopic residual tumor at bronchial resection margins is a concern after pulmonary carcinoma surgery.
- Bronchopleural fistula (BPF) is a serious complication following lung cancer resection.
Purpose of the Study:
- To investigate the incidence of BPF in patients with microscopic residual carcinoma in bronchial resection lines.
- To evaluate the impact of residual carcinoma on BPF development and long-term prognosis.
- To assess the benefit of intraoperative frozen sections and postoperative radiotherapy.
Main Methods:
- Retrospective analysis of 1069 patients undergoing pulmonary carcinoma resection.
- Correlation of postoperative BPF incidence with microscopic residual tumor.
- Comparison of survival rates based on residual tumor status and treatment modalities.
Main Results:
- Microscopic residual carcinoma was found in 44 patients (4.1%).
- BPF developed in 13.6% of patients with residual carcinoma versus 4.2% overall (p<0.01).
- Residual carcinoma did not worsen prognosis; survival was similar to patients with clear margins and same TNM staging.
Conclusions:
- Intraoperative frozen sections of bronchial resection lines are recommended to detect residual carcinoma and reduce BPF incidence.
- Postoperative radiotherapy may improve prognosis in patients with residual tumor growth.
- Early detection and management of residual carcinoma are crucial for optimizing outcomes in lung cancer surgery.